Literature DB >> 31251443

Patient assessment and selection for pulmonary rehabilitation.

Carolyn L Rochester1,2.   

Abstract

Pulmonary rehabilitation (PR) is beneficial for people with several forms of chronic respiratory disease. Given the existing limitations on availability of PR services, it is important to identify participants who are most likely to benefit from it. Identification of criteria for patient referral to PR is challenging, as chronic respiratory diseases and their medical and psychosocial co-morbidities place a complex and multifaceted burden on patients. Although research studies have attempted to identify key parameters predictive of 'responsiveness to PR', to date no firm physiological, psychosocial or other criteria exist by which optimal patient candidacy can be determined. Moreover, individual factors do not reliably predict successful multidimensional PR outcomes. In general, individuals who remain symptomatic with dyspnoea, fatigue and exercise intolerance; who have difficulty performing activities of daily living (ADL); and who are having difficulty coping with or managing their disease despite optimized pharmacological therapy are potential candidates for PR. Patient assessment and outcome measurement are core essential features of PR. To be considered as a PR programme, rehabilitation programmes must demonstrate, at a minimum, assessment and outcome measurement in regard to exercise capacity, dyspnoea and health-related quality of life. Additional parameters, including physical activity, nutritional status, tobacco use status, patient knowledge and self-efficacy, performance of ADL, fatigue, disease exacerbations, hospitalizations and other urgent healthcare utilization, and behavioural outcomes, including coping styles, patient satisfaction and programme metrics, are other relevant and important aspects of patient assessment and outcome measurement that should be considered and undertaken in PR, where feasible.
© 2019 Asian Pacific Society of Respirology.

Entities:  

Keywords:  lung diseases; outcome assessment; patient selection; patients; rehabilitation

Mesh:

Year:  2019        PMID: 31251443     DOI: 10.1111/resp.13616

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

1.  Pulmonary Rehabilitation Reduces Subjective Fatigue in COPD: A Responder Analysis.

Authors:  Maarten Van Herck; Jeanine Antons; Jan H Vercoulen; Yvonne M J Goërtz; Zjala Ebadi; Chris Burtin; Daisy J A Janssen; Melissa S Y Thong; Jacqueline Otker; Arnold Coors; Mirjam A G Sprangers; Jean W M Muris; Judith B Prins; Martijn A Spruit; Jeannette B Peters
Journal:  J Clin Med       Date:  2019-08-20       Impact factor: 4.241

2.  What Motivates Patients with COPD to Be Physically Active? A Cross-Sectional Study.

Authors:  Sara Pimenta; Cândida G Silva; Sofia Flora; Nádia Hipólito; Chris Burtin; Ana Oliveira; Nuno Morais; Marcelo Brites-Pereira; Bruno P Carreira; Filipa Januário; Lília Andrade; Vitória Martins; Fátima Rodrigues; Dina Brooks; Alda Marques; Joana Cruz
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

3.  Deriving personalised physical activity intensity thresholds by merging accelerometry with field-based walking tests: Implications for pulmonary rehabilitation.

Authors:  Ilaria Pina; Pauline Ndagire; Winceslaus Katagira; Lorna Latimer; Jakub Zatloukal; Bruce Kirenga; Sally J Singh; Mark W Orme
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

Review 4.  The narrative review of chronic obstructive pulmonary disease management in Turkey: medical treatment, pulmonary rehabilitation and endobronchial volume reduction.

Authors:  Ipek Candemir
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

5.  Exploration of n-6 and n-3 Polyunsaturated Fatty Acids Metabolites Associated with Nutritional Levels in Patients with Severe Stable Chronic Obstructive Pulmonary Disease.

Authors:  Mingshan Xue; Chuanxu Cai; Lili Guan; Yifan Xu; Jinsheng Lin; Yifeng Zeng; Haisheng Hu; Rongchang Chen; Hongman Wang; Luqian Zhou; Baoqing Sun
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.